NCT05721209

Brief Summary

This pilot study aims to determine the feasibility of a virtual reality treadmill training intervention in individuals with Traumatic Brain Injury (TBI). Participants will be stratified based on age into adults' group or older adults' group and then randomized into the virtual reality treadmill training (intervention) group with feedback or the treadmill training (control) group. This pilot study will also provide preliminary evidence on the impact of the virtual reality treadmill training on mobility, balance, fear of falls, fall risk, attention and physical activity in the community in individuals with TBI. The data collected in this pilot study will also help to estimate sample size for subsequent large clinical trial.

Trial Health

53
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial recruitment is currently suspended
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
7mo left

Started May 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
May 2023Dec 2026

First Submitted

Initial submission to the registry

January 31, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 9, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

May 3, 2023

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 23, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 23, 2026

Last Updated

January 7, 2026

Status Verified

January 1, 2026

Enrollment Period

3.6 years

First QC Date

January 31, 2023

Last Update Submit

January 5, 2026

Conditions

Outcome Measures

Primary Outcomes (4)

  • Recruitment Rate

    Recruitment rate is defined as the number of patients recruited on average for one month in one site.

    Up to Week 10

  • Enrollment Rate

    Enrollment Rate defined as the percentage of recruited participants who enrolled in the study.

    Up to Week 10

  • Retention Rate

    Retention rate defined as the percentage of enrolled participants who completed the study.

    Up to Week 10

  • Percentage of Participants who Adhere to 100% of Study Procedures

    Up to Week 10

Secondary Outcomes (1)

  • Change from Baseline in Falls Self-Efficacy Scale (FES-I) Score by Final Intervention Visit

    Baseline, Week 7

Study Arms (4)

VRTT With Feedback - Adults

EXPERIMENTAL

Adults aged 18-65 with TBI. At Week 1 after baseline, participants will begin study intervention on the C-Mill with augmented/virtual reality (AR/VR) guidance. Starting at Week 2, the study intervention on C-Mill will be repeated 3 sessions/week for 8 weeks. Each one hour session will include about 15 minutes of standing balance training, about 5 minutes of stepping balance training and about 30 minutes of walking training on the C-Mill with AR/VR feedback.

Device: C-Mill with AR/VR GuidanceDevice: Zeno 3-Layer WalkwayDevice: Hunova

VRTT With Feedback - Older Adults

EXPERIMENTAL

Adults aged 65 and older with TBI. At Week 1 after baseline, participants will begin study intervention on the C-Mill with augmented/virtual reality (AR/VR) guidance. Starting at Week 2, the study intervention on C-Mill will be repeated 3 sessions/week for 8 weeks. Each one hour session will include about 15 minutes of standing balance training, about 5 minutes of stepping balance training and about 30 minutes of walking training on the C-Mill with AR/VR feedback.

Device: C-Mill with AR/VR GuidanceDevice: Zeno 3-Layer WalkwayDevice: Hunova

VRTT Without Feedback - Adults

ACTIVE COMPARATOR

Adults aged 18-65 with TBI. At Week 1 after baseline, participants will begin study intervention on the C-Mill without augmented/virtual reality (AR/VR) guidance. Starting at Week 2, the study intervention on C-Mill will be repeated 3 sessions/week for 8 weeks. Each one hour session will include about 15 minutes of standing balance training, about 5 minutes of stepping balance training and about 30 minutes of walking training on the C-Mill without AR/VR feedback.

Device: C-Mill without AR/VR GuidanceDevice: Zeno 3-Layer WalkwayDevice: Hunova

VRTT Without Feedback - Older Adults

ACTIVE COMPARATOR

Adults aged 65 and older with TBI. At Week 1 after baseline, participants will begin study intervention on the C-Mill without augmented/virtual reality (AR/VR) guidance. Starting at Week 2, the study intervention on C-Mill will be repeated 3 sessions/week for 8 weeks. Each one hour session will include about 15 minutes of standing balance training, about 5 minutes of stepping balance training and about 30 minutes of walking training on the C-Mill without AR/VR feedback.

Device: C-Mill without AR/VR GuidanceDevice: Zeno 3-Layer WalkwayDevice: Hunova

Interventions

HunovaDEVICE

Used to conduct fall-risk assessment.

VRTT With Feedback - AdultsVRTT With Feedback - Older AdultsVRTT Without Feedback - AdultsVRTT Without Feedback - Older Adults

Treadmill training system that is a combination of an instrumented treadmill, front display, and a floor projector, allowing functional gait and balance training. The AR/VR feedback will include computer generated obstacles and objects projected as images on the treadmill. Participants will be asked to use these projections as stepping cues and step on some images of objects while avoiding stepping on the images of obstacles.

VRTT With Feedback - AdultsVRTT With Feedback - Older Adults

Treadmill training system that is a combination of an instrumented treadmill, front display, and a floor projector, allowing functional gait and balance training.

VRTT Without Feedback - AdultsVRTT Without Feedback - Older Adults

Used to conduct mobility assessments to assess temporal and spatial gait parameters during the 6-minute walk test.

VRTT With Feedback - AdultsVRTT With Feedback - Older AdultsVRTT Without Feedback - AdultsVRTT Without Feedback - Older Adults

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • to 90 years old
  • diagnosed with a non-penetrating TBI
  • at least 12 months post most recent injury
  • self-reported balance deficits and fear of falls or at least 2 falls in the last one year
  • Able to understand and speak English language to respond, understand and comply with study procedures throughout the 10-week study period and fill out the study questionnaires in English
  • Able to walk with minimal assistance or less (with bracing and assistive devices as needed)

You may not qualify if:

  • history of severe cardiac disease
  • neuromuscular or neurological pathologies other than TBI that limit study participation
  • uncontrolled seizure disorder
  • weight greater than 135 kg or less than 25 kg
  • height greater than 6' 2''
  • severe cognitive, visual or hearing impairment where the patient is not able to follow the study instructions
  • open skin lesion or bandage in the area of C-Mill harness contact

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NYU Langone Health

New York, New York, 10016, United States

Location

MeSH Terms

Conditions

Brain Injuries, Traumatic

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Akhila Veerubhotla, PhD

    NYU Langone Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 31, 2023

First Posted

February 9, 2023

Study Start

May 3, 2023

Primary Completion (Estimated)

December 23, 2026

Study Completion (Estimated)

December 23, 2026

Last Updated

January 7, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Shared data will be aggregated and deidentified. No IPD will be shared with other researchers.

Locations